Stacy Lindborg
CIK 1813667 · President and CEO · last filed 2026-07-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$126.1K
Companies
3
Total Filings
29
Lifetime Open-Market Net
$44.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMNN | President and CEO | 82,407 | $1.53 | $126.1K | $24.5K | 17 | 2026-07-21 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted | Co-Chief Executive Officer | 48,229 | $0.75 | $36.1K | $20.4K | 8 | 2025-01-03 |
| Imunon, Inc. (CLSN) Delisted | Director | — | $1.96 | — | $0 | 3 | 2022-06-15 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-18 | IMNN | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-10-31 | IMNN | Grant (A) | — | $0 | EDGAR |
| 2024-09-10 | IMNN | Grant (A) | — | $0 | EDGAR |
| 2024-08-16 | IMNN | Buy (P) | +25,000 | $24.5K | EDGAR |
| 2024-06-14 | IMNN | Grant (A) | — | $0 | EDGAR |
| 2024-05-14 | IMNN | Grant (A) | — | $0 | EDGAR |
| 2024-03-18 | IMNN | Grant (A) | — | $0 | EDGAR |
| 2024-03-13 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted | Grant (A) | +241,935 | $0 | EDGAR |
| 2023-09-05 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted | Buy (P) | +11,500 | $20.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.